IRIS
CARLOMAGNO, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.172
EU - Europa 1.426
AS - Asia 858
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
SA - Sud America 1
Totale 4.500
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.128
IT - Italia 596
SG - Singapore 416
CN - Cina 394
NL - Olanda 249
IE - Irlanda 154
FI - Finlandia 125
UA - Ucraina 108
DE - Germania 60
SE - Svezia 57
CI - Costa d'Avorio 39
CA - Canada 37
GB - Regno Unito 31
FR - Francia 23
IN - India 18
CZ - Repubblica Ceca 11
VN - Vietnam 10
IR - Iran 7
BE - Belgio 6
JO - Giordania 4
MX - Messico 4
EU - Europa 3
HK - Hong Kong 3
ES - Italia 2
JP - Giappone 2
KR - Corea 2
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
CR - Costa Rica 1
EE - Estonia 1
KN - Saint Kitts e Nevis 1
NO - Norvegia 1
PK - Pakistan 1
PR - Porto Rico 1
PT - Portogallo 1
TR - Turchia 1
Totale 4.500
Salva come PNG Salva come JPEG
Città #
Singapore 345
Chandler 328
Amsterdam 246
Millbury 171
Ashburn 146
Princeton 127
Napoli 120
Beijing 112
Nanjing 100
Santa Clara 91
Jacksonville 76
Naples 62
Wilmington 59
Boston 53
Nanchang 44
Des Moines 41
Ottawa 34
Tianjin 23
Jiaxing 21
Houston 18
Shenyang 18
Washington 17
Ann Arbor 15
Lawrence 15
Woodbridge 14
Hebei 13
Milan 13
Norwalk 12
Falls Church 10
Indiana 10
Kunming 10
Olomouc 10
Redwood City 10
Lentini 9
Munich 9
Rome 9
Changsha 8
Dong Ket 8
Torre Annunziata 8
Boardman 7
Dallas 7
Kronberg 7
Dublin 6
Pune 6
Rozzano 6
New York 5
Amman 4
Castellammare di Stabia 4
Fairfield 4
Los Angeles 4
Menfi 4
Salerno 4
San Mateo 4
Bari 3
Brescia 3
Cambridge 3
Catania 3
Fremont 3
Hong Kong 3
Lanzhou 3
Leawood 3
Menlo Park 3
Mugnano Di Napoli 3
Pompei 3
Prineville 3
Sciacca 3
Seattle 3
Serravalle Scrivia 3
Shanghai 3
Villaricca 3
Villarosa 3
Acerra 2
Afragola 2
Barcelona 2
Bientina 2
Caserta 2
Casoria 2
Castel San Giorgio 2
Castellammare Di Stabia 2
Changchun 2
Courcelles 2
Delhi 2
Edegem 2
Edinburgh 2
Frankfurt am Main 2
Genova 2
Hangzhou 2
Hanoi 2
Helsinki 2
Hicksville 2
Jersey City 2
Latina 2
Mariano Comense 2
Messina 2
Newbury Park 2
Nola 2
Noventa di Piave 2
Nutley 2
Orange 2
Pachuca 2
Totale 2.619
Salva come PNG Salva come JPEG
Nome #
null 223
Manuale di Oncologia Clinica 101
STATO DELL'ARTE SULLA CHEMIOTERAPIA NEL CANCRO DEL COLON 83
null 67
Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: a phase II study. 64
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study. 63
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study. 62
Discordance in RAS mutations between primary colon tumor and metastases: a real event or a matter of methodology? 56
Management of patients with BRCA1/2-associated breast cancer 55
A case report of limbic encephalitis in a metastatic colon cancer patient during first-line bevacizumab-combined chemotherapy 54
Less frequently mutated genes in colorectal cancer: Evidences from next-generation sequencing of 653 routine cases 53
Addition of erlotinib to fluoropyrimidine-oxaliplatin-basedchemotherapy with or without bevacizumab: Two sequential phase I trials 52
Fast Detection of a BRCA2 Large Genomic Duplication by Next Generation Sequencing as a Single Procedure: A Case Report. 49
Raltitrexed versus standard leucovorin-modulated 5Fluorouracil: results form the randomized phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1). 48
The Epithelial-Stromal Interaction as a Potential Target for Breast Cancer Treatment 48
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients 46
A Metanalysis on the Interaction between HER2 Expression and Response to Endocrine Treatment in Advanced Breast Cancer 44
Bevacizumab related arterial hypertension as a predictive marker in metastatic Colorectal Cancer (mCRC) patients 44
EGFR mutations detected on cytology samples by a centralized laboratory reliably predict response to gefitinib in non-small cell lung carcinoma patients. 44
Two novel sequence variants in MSH2 gene in a patient who underwent cancer genetic counseling for a very early-onset epithelial ovarian cancer 44
Bevacizumab as 4th line treatment in metastatic colorectal cancer 43
FOLFOXIRI/bevacizumab (bev) versus FOLFIRI/bev as first-line treatment in unresectable metastatic colorectal cancer (mCRC) patients (pts): Results of the phase III TRIBE trial by GONO group. 43
UbcH10 expression can predict prognosis and sensitivity to the antineoplastic treatment for colorectal cancer patients 43
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer. 41
Capecitabine plus weekly oxaliplatin in gastrointestinal tumors: a phase I study. 41
Vinorelbine + mitomycin C as second-line treatment of metastatic breast cancer: a two-stage phase 2 study. 41
A phase I study of paclitaxel and epirubicin, without and with filgrastim, for the treatment of platinum-resistant advanced ovarian cancer. 41
A phase II study of beweekly oxaliplatin plus infusional 5fluorouracil and folinic acid (FOLFOX4) as first-line treatment of advenced gastric cancer patients 41
Role of sphingosine kinase 1 (SphK1) on cetuximab resistance in colorectal cancer models 40
KRAS Mutant Allele Specific Imbalance (MASI) assessment in routine samples of metastatic colorectal cancer patients 40
A predictive index of axillary nodal involvement in operable breast cancer. 39
Phase I-II study of xelox and bevacizumab plus erlotinib in sequential combination (XELOX-TARAV) in first line colorectal cancer: run in part 39
Concomitant Interferon-alfa and chemotherapy in hepatitis C and colorectal cancer: a case report 39
Prolactin receptor does not correlate with oestrogen and progesterone receptors in primary breast cancer and lacks prognostic significance. Ten year results of the Naples adjuvant (GUN) study. 38
Double complete response in MCRC patient 38
Risk factors for cancer-related venous thromboembolism in ambulatory patients. 38
Adjuvant treatment for locally advanced rectal cancer patients after pre-operative chemoradiotherapy: when, and for whom? 38
C-erbB2 overexpression decreases the benefit of adiuvant tamoxifen in early breast cancer without axillary lymph node metastases. 37
The impact of schedule on acute toxicity and dose-intensity of high-dose chemotherapy with epirubicin and cyclophosphamide plus colony stimulating factors in advanced breast cancer. 37
Adjuvant FOLFOX-4 in patients with radically resected gastric cancer: tolerability, and prognostic factors. 37
A specific miRNA signature correlates with complete pathological response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer 37
Basaloid Squamous Cell Carcinoma: A Rare Tumor at the Esophagogastric Junction and an Unexpected Durable Complete Response to FOLFOX-4. 37
Cancro del colon-retto 36
Primary hepatic lymphoma in a patient with previous rectal adenocarcinoma: a case report and discussion ofetiopathogenesis and diagnostic tools 36
An unusual case of primary choriocarcinoma of the lung 36
Analysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patients 36
Prognostic significance of multifocality in primary breast cancer. 35
Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: a phase II study. 35
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial. 35
High-rsolution melting analysis (HRMA) for KRAS mutatiinal study in patients with metastatic colorectal cancer (mCRC pts) 35
Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review 35
Prognostic role of sarcopenia in metastatic colorectal cancer patients during first-line chemotherapy: A retrospective study 35
Ovarian metastasis following gallbladder carcinoma: a case report. 34
Altri tumori gastrointestinali 34
Cytological diagnosis of thyroid nodules in Hashimoto thyroiditis in elderly patients 34
Endocrine factors in the outcome of systemic adjuvant therapy of early breast cancer. 33
Second-line chemotherapy with a hybrid-alternating regimen of bolus 5FU modulated by methotrexate and infusional 5FU modulated by folinic acid in patients with metastatic colorectal cancer pretreated with 5FU. A phase 2 study. 33
CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study). 33
MULTIPLE PRIMARY MALIGNANT NEOPLASM AND FAMILIAR ANAMNESIS 33
HER2 as predictive marker of resistance to endocrine treatment for advanced bresat cancer: a metanalysis of published studies 33
KRAS testing in metastatic colorectal carcinoma: challenges, controversies, breakthroughs, and beyond 33
A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients. 33
Next-generation sequencing in the genomic profiling of synchronous colonic carcinomas: comment on Li et al (2015) 33
Core curriculum. Oncologia clinica 33
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. 32
MULTIDISCIPLINARY APPROACH TO PATIENTS WITH MALIGNANT MELANOMA 32
DNA-flow cytometry (ploidy and s-phase fraction) as prognostic factor in a retrospective series of 515 primary breast-cancer 32
Bevacizumab-induced hypertension is a predictive marker of response and progression free survival in patients treated for metastatic colorectal cancer 31
MicroRNA profiling as predictive factor of complete pathological response to neoadjuvant chemoradiothetapy in patients with locally advanced cancer 31
FOLFOXIRI plus bevacizumab (bev) versus FOLFIRI plus bev as first-line treatment of metastatic coloectal cancer (MCRC): results of the phase III tandomized TRIBE trial 31
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study 31
Correlation between bevacizumab-related hypertension and response in mCRC patients 30
Sphingosine Kinase 1 (SphK1) overespression contributes to cetuximab resistance in human colrectal cancer. 30
FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience 30
Prognostic significance of necrosis, elestosis, fibrosis and inflammatory cell reaction in operable breast cancer. 29
Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer patients. A phase II study. 29
microRNA come parametri predittivi di risposta ai farmaci a bersaglio molecolare specifico nelle neoplasie del colon-retto 29
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as initial treatment for metastatic colorectal cancer (TRIBE study): updated survival results and final molecular subgroups analyses. 29
Forearm cutaneous metastasis of rectal adenocarcinoma: a case report 29
Adjuvant chemoendocrine therapy for early breast cancer: is it worthwhile? 28
Chemotherapy with mitomycin C and vinblastine in pretreated metastatic breast cancer. 28
Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-lerm follow-up. 27
Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region. 27
Bevacizumab maintenance in metastatic colorectal cancer: How long? 27
KRAS mutation detection by high resolution melting analysis significantly predicts clinical benefit of cetuximab in metastatic colorectal cancer 26
Unusual case of exacerbation of sub-acute descending necrotizing mediastinitis 26
Multiple treatment lines and prognosis in metastatic colorectal cancer patients 26
Identification of a novel truncating mutation in PALB2 gene by a multigene sequencing panel for mutational screening of breast cancer risk-associated and related genes 26
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial 26
Il punto sull’Irinotecan: presente e futuro 25
Neoadjuvant treatment with capecitabine and oxaliplatin in combination with radiotherapy for rectal cancer patients: a phase II study 25
Core curriculum. Oncologia clinica 25
Beyond KRAS: Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer 24
A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme) 24
SANGER SEQUENCING IN ROUTINE KRAS TESTING: AREVIEW OF 1720 CASES FROM A PATHOLOGIST’SPERSPECTIVE 23
Predictive factors of complete response to neoadjuvant chemoradiotherapy in patients with rectal cancer 22
Cancro del colon-retto 22
Surgery in lung cancer metastasis 22
Molecules and mechanisms to overcome oxidative stress inducing cardiovascular disease in cancer patients 22
The first breast cancer screening program in southern Italy: preliminary results from three municipalities of the Naples Province. 21
Totale 3.898
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.313
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.313
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020221 0 0 0 0 20 7 6 12 2 50 71 53
2020/2021379 12 17 37 26 37 71 23 25 56 27 29 19
2021/2022840 14 3 5 7 1 26 7 43 165 78 165 326
2022/20231.009 146 59 26 50 95 87 6 89 155 240 40 16
2023/2024631 29 91 77 60 29 76 11 75 4 5 112 62
2024/2025584 188 244 14 38 100 0 0 0 0 0 0 0
Totale 4.664